EPISODE · Oct 25, 2023 · 43 MIN
Biotech Advisory vs Consultancy with David Cao, Founder of Target2Drug BioAdvisory
from Building Biotechs
This week, we chatted with David Cao, Founder of Target2Drug BioAdvisory, an advisory firm dedicated to helping small biotechs make smarter and faster business and commercial strategic decisions. Topics we Discuss:The difference between a biotech advisory and a consulting firmThe joys of working with startupsWhen to bring biotech advisors inHow Target2Drug came to be01:25 - 05:36 - It’s Okay Not to Know06:30 - 08:44 - An Advisory Role, Not a Consulting Firm08:56 - 13:40 - When Should Startups Bring Advisors In?Get David's favorite book: Living: Inspiration from a Father with CancerTarget2Drug Bio AdvisoryLink In with David!Connect with us!Link In with CarinaSubscribe here:AppleSpotifyGoogle PodcastRSS feedLearn more about Recruitomics ConsultingCheck out our reading listDownload our free startup resources guide to grow your biotech efficientlyIf you're on the job market, visit the Collaboratory Career Hub Building Biotechs: A Podcast by Recruitomics Consulting is handcrafted by our friends over at: fame.so
Embed this episode
What this episode covers
In this episode of Building Biotechs: A Podcast by Recruitomics Consulting, we’re joined by David Cao, Founder of Target2Drug BioAdvisory. Join us as we delve into the differences between biotech advisories and consultancies, and why working with startups is such a joyful experience!
NOW PLAYING
Biotech Advisory vs Consultancy with David Cao, Founder of Target2Drug BioAdvisory
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.